Core Insights - The company is a leading player in China's industrial X-ray source and detection equipment sector, breaking the overseas monopoly in integrated circuits, electronic manufacturing, new energy batteries, and material testing, thus facilitating domestic substitution [1][2]. Business Overview - In 2024, the company reported a revenue of 740 million yuan and a net profit attributable to shareholders of 140 million yuan, with a non-recurring net profit of 95 million yuan. The revenue structure for the first half of 2024 shows that X-ray detection equipment, spare parts, and others accounted for 87% and 12% of total revenue, with gross margins of 41% and 74% respectively [2][3]. - The X-ray detection equipment business includes revenue contributions from integrated circuit electronic manufacturing (41%), cast products (27%), and new energy battery automatic detection systems (17%), with corresponding gross margins of 48%, 37%, and 33% [2][3]. Market Position and Competitive Advantage - The company has achieved a breakthrough in micro-focus X-ray sources, establishing a competitive landscape with Japanese and American firms, creating a tripartite competition in the global market [2]. - The company is positioned to benefit from high-end product breakthroughs and the drive for import substitution, indicating significant growth potential [2][3]. Financial Performance and Projections - The company’s revenue from high-end spare parts has reached 12% of total revenue in the first half of 2024, with a high gross margin of 74%. The revenue from X-ray detection equipment for integrated circuit manufacturing grew by 32% in the first half of 2024, indicating strong demand and growth potential in this sector [3]. - The company has a robust cash flow with approximately 2.4 billion yuan in cash equivalents as of the third quarter of 2024, providing a solid foundation for future development [3]. Profit Forecast and Valuation - The projected net profits for the company from 2024 to 2026 are 140 million yuan, 220 million yuan, and 300 million yuan, representing year-on-year growth rates of 24%, 55%, and 38% respectively. The corresponding price-to-earnings ratios are expected to be 50, 32, and 24 times [4]. - The anticipated tariff policies are expected to accelerate the domestic production of X-ray sources and detection equipment, potentially increasing the company's market share. A target price of 85.98 yuan is set for 2025, with a recommended "buy" rating [4].

导读： 多浦乐2024年实现营业收入1.62亿元，同比下降18.70%；归属于上市公司股东的净利润为0.52亿元，同比下降33.68%。 特别提示 微信公众号机制调整，请点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 近日，广州多浦乐电子科技股份有限公司（简称：多浦乐）发布了2 0 2 4年度报告。报告显示，多浦乐全年实现营业收入1 . 6 2亿元，同比下降 1 8 . 7 0%；归属于上市公司股东的净利润为0 . 5 2亿元，同比下降3 3 . 6 8%。尽管业绩承压，多浦乐在技术创新和市场拓展方面持续发力，未来战 略聚焦医疗领域和自动化检测设备，力争实现业务多元化发展。 2 0 2 4年，多浦乐的收入主要来源于工业无损检测设备、超声换能器及配套零部件的销售。其中，工业无损检测设备实现营业收入7 , 0 4 5 . 1 9万 元，同比下降2 7 . 1 8%；超声换能器收入5 , 6 7 3 . 9 9万元，同比下降11 . 3 7%；配套零部件收入3 , 2 1 5 . 1 7万元，同比下降8 . 0 8%。 公司表示，营收下滑的主要原因是国内经济增速放缓导致 ...